Organon & Co. OGN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.57B | 1.56B | 1.46B | 1.51B | 1.60B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.57B | 1.56B | 1.46B | 1.51B | 1.60B |
| Cost of Revenue | 705.00M | 711.00M | 670.00M | 741.00M | 733.00M |
| Gross Profit | 869.00M | 847.00M | 790.00M | 766.00M | 869.00M |
| SG&A Expenses | 421.00M | 434.00M | 424.00M | 431.00M | 415.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.21B | 1.24B | 1.19B | 1.26B | 1.23B |
| Operating Income | 365.00M | 323.00M | 273.00M | 244.00M | 370.00M |
| Income Before Tax | 255.00M | 183.00M | 213.00M | -148.00M | 243.00M |
| Income Tax Expenses | 91.00M | 75.00M | 67.00M | 57.00M | 83.00M |
| Earnings from Continuing Operations | 164.00M | 108.00M | 146.00M | -205.00M | 160.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 164.00M | 108.00M | 146.00M | -205.00M | 160.00M |
| EBIT | 365.00M | 323.00M | 273.00M | 244.00M | 370.00M |
| EBITDA | 447.00M | 403.00M | 359.00M | 340.00M | 462.00M |
| EPS Basic | 0.62 | 0.41 | 0.56 | -0.79 | 0.62 |
| Normalized Basic EPS | 0.63 | 0.50 | 0.41 | 0.25 | 0.61 |
| EPS Diluted | 0.60 | 0.40 | 0.55 | -0.79 | 0.61 |
| Normalized Diluted EPS | 0.61 | 0.49 | 0.40 | 0.25 | 0.61 |
| Average Basic Shares Outstanding | 262.62M | 262.61M | 260.37M | 260.17M | 259.98M |
| Average Diluted Shares Outstanding | 272.38M | 270.45M | 262.90M | 260.17M | 260.65M |
| Dividend Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Payout Ratio | 3.05% | 5.56% | 3.42% | -1.95% | 1.88% |